January 4, 2023 Ann Arbor, MI

Genomenon Announces Participation in BIO Partnering @JPM Week 2024

Executive Team to share the critical need of genomic information to support evidence-based decisions at every phase of drug programs

Genomenon, a genomic intelligence company, announced that it will be participating in BIO Partnering @JPM Week 2024, which takes place from January 8th to January 12th in San Francisco, California.

Details of the event are as follows:

Event: BIO Partnering @JPM Week
Date: January 8-12, 2024

Genomenon executives will be available to conduct one-on-one meetings with registered pharmaceutical companies and investors. They are looking to raise awareness within cancer and genetic disease therapeutics regarding the hidden costs caused by a lack of access to comprehensive genomic information at every phase of a drug program. Schedule your meeting with the Genomenon’s leadership team by connecting with one of our team members through the BIO Partnering system.

About Genomenon:

Genomenon is a leading genomic intelligence company dedicated to improving the quality of patients’ lives by uncovering the genomic drivers of genetic disease and cancer. Blending the power of AI with genomic expertise, Genomenon simplifies complex genetic data into actionable insights for patient diagnosis and precision medicine development. The company’s solutions include software, data, and curation and consulting services.

About BIO

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the U.S. and in more than 30 other nations.

BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.

For more information, visit